SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (133)10/5/2002 12:43:34 PM
From: nigel bates  Read Replies (2) | Respond to of 684
 
Thanks for the update. It's certainly saved me a lot of time this weekend. (Shame that many will be reporting this month, and messing up the figures all over again...).

A couple of stocks are missing that should really be there - OGSI ($125m; $225m), VICL ($56m; $112m) and possibly NGEN ($36m; $51m).

As as this is an RWR thread, then maybe microcaps INSM, GNSC and RZYM should be on the list, too.

Just missing the cut, trading around cash - and presumably well off the list next time they report - are CRXL, AMEV, IMGN and LSBC.

I too have ignored CRA. <g>



To: rkrw who wrote (133)10/6/2002 8:01:25 PM
From: farkarooski  Read Replies (1) | Respond to of 684
 
is CRA a biotech company, if so, they are below cash too ...



To: rkrw who wrote (133)10/7/2002 2:29:05 PM
From: Czechsinthemail  Respond to of 684
 
The CEO just bought over $300,000 worth of TTP stock (200,000 shares). Maybe the list of biotech companies trading below cash provided a wakeup. TTP is one trading well below net cash.

Message 18082098